Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02385253 · ClinicalTrials.gov registry record · NA
Training Primary Care Physicians to Perform Melanoma Opportunistic Surveillance
A NA study of Melanoma and Nevi, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 89
- Enrollment target
- 2
- Study locations
NCT02385253 is a NA study of Melanoma and Nevi that has completed, run by Northwestern University. The registered enrollment target is 89 participants, below the 706-participant average among 266 other Melanoma trials with a reported enrollment target (87% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT02385253, a NA study of Melanoma and Nevi, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 89 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is a four-phase educational intervention for primary care practitioners (PCPs) to perform opportunistic melanoma surveillance. Based on prior research, the investigator will develop an interactive melanoma early detection skills training program for PCPs according to the principals of mastery learning. The proposed educational intervention will improve practicing PCPs' knowledge, competence, confidence, and diagnostic performance regarding pigmented lesions and attitude concerning importance of skin surveillance. In addition, this research aims to examine the clinical proficiency of PCPs regarding pigmented lesions. The proposed educational intervention will reduce the percentage of benign lesions referred to dermatology.
Conditions Studied
Interventions
- BEHAVIORAL Educational training program
Study Locations (2)
Illinois
- Northwestern Medicine: Division of General Internal Medicine and Geriatrics - Chicago
- Northwestern University Feinberg School of Medicine Department of Dermatology - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 89 participants |
| Start Date | 2015-09-15 |
| Est. Completion | 2017-07-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02385253
The ClinicalTrials.gov registry entry for NCT02385253 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 89 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 706-participant average among 266 other Melanoma trials with a reported enrollment target (87% lower). The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Melanoma appearing as the primary indexed condition, and to 1 intervention - of which Educational training program is the first listed.
NCT02385253 reports 2 study locations spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT02385253 about?
NCT02385253 is a clinical study titled "Training Primary Care Physicians to Perform Melanoma Opportunistic Surveillance". This is a four-phase educational intervention for primary care practitioners (PCPs) to perform opportunistic melanoma surveillance. Based on prior research, the investigator will develop an interactive melanoma early detection skills training program for PCPs according to the principals of mastery l...
What is the current status of trial NCT02385253?
This trial is currently completed. It is a NA study. The enrollment target is 89 participants. The study started on 2015-09-15. Estimated completion is 2017-07-23.
What conditions does trial NCT02385253 study?
This clinical trial studies the following conditions: Melanoma, Nevi, Skin Moles.
What interventions are being tested in trial NCT02385253?
The interventions under investigation include: Educational training program (BEHAVIORAL).
Who is sponsoring clinical trial NCT02385253?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02385253 being conducted?
This trial has 2 study locations across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Melanoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma
RECRUITING · NA
-
Promoting Immunotherapy Efficacy With Low-Dose Liver RT
RECRUITING · NA
-
A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
RECRUITING · NA
-
MySmartSkin Online Skin Self-exam Intervention for Melanoma Survivors
RECRUITING · NA
-
Studying Quality of Life Inclusive of Mental Health and Cognitive Behavioral Therapy for Cancer Distress for the Improvement of Quality of Life in Stage III-IV Melanoma Patients
RECRUITING · NA
-
High Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver Malignancies
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.